CCL2 and colorectal carcinoma: Our group has recently shown that CEACAM1-L expression in murine MC38 poorly differentiated CRC cells dramatically reduced experimental liver metastasis as a consequence of diminished STAT3 activity and lessened CCL2 chemokine expression [22].